The Co-Transduction Conundrum: Improving Dual rAAV Delivery Through Co-Administration of Capsid Serotypes With Complementary Tropism
Translational Vision Science & Technology · 2025
DOI: 10.1167/tvst.14.11.38 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2025. Verfasst von Rachel L Fehrman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Transduction, Genetic, Genetic Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Purpose
Recombinant adeno-associated virus (rAAV) vectors are promising tools for the treatment of inherited retinal diseases (IRDs) but have a limited carrying capacity for therapeutic cassettes of up to 4.8 kilobase (kb). To circumvent this limitation, multiple vector approaches have been proposed wherein the transgene cassette is split across two or more rAAV vector genomes. In this study, we examine whether rAAV serotype choice has an effect on co-transduction of retinal cells following subretinal delivery and whether co-transduction represents a rate-limiting step preventing successful large transgene delivery.
Methods
The rAAV vector serotypes with known photoreceptor affinity (rAAV2/5, rAAV2/8, and rAAV2/9) packaging fluorescent reporter genes (GFP or mCherry) were co-delivered to C57Bl/6J mice via subretinal injection in all combinations of serotype. Two to 3 weeks following injection, confocal scanning laser ophthalmoscopy (cSLO) imaging and immunohistochemistry was used to visualize the extent of transduction and flow cytometry was utilized to quantify co-transduction of retinal cells.
Results
Fluorescent GFP and mCherry transgene expression was observed by in vivo cSLO imaging in all injected eyes. Flow cytometry showed that the highest rate of co-transduction came from co-administration of rAAV2/8.mCherry and rAAV2/9.GFP (87.43 ± 3.84%) with considerable overlap in the expression observed. The lowest rate of co-transduction resulted from the co-delivery of rAAV2/5.mCherry and rAAV2/8.GFP (36.57 ± 4.79%) with cSLO imaging showing minimal overlap in fluorescent expression.
Conclusions
Utilizing a combination of rAAV capsids with similar cellular tropisms for dual rAAV delivery can result in an increased efficiency of co-transduction but is serotype dependent. Translational Relevance: Identification of bottlenecks in rAAV transduction may improve the efficiency of large transgene delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
- Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.
Förderung
- NEI NIH HHS
- NIH HHS
Zitieren
APA
Fehrman, R. L., & Lipinski, D. M. (2025). The Co-Transduction Conundrum: Improving Dual rAAV Delivery Through Co-Administration of Capsid Serotypes With Complementary Tropism. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.14.11.38
Vancouver
Fehrman RL, Lipinski DM. The Co-Transduction Conundrum: Improving Dual rAAV Delivery Through Co-Administration of Capsid Serotypes With Complementary Tropism. Translational Vision Science & Technology. 2025. doi:10.1167/tvst.14.11.38
BibTeX
@article{Fehrman2025,
author = {Fehrman, Rachel L and Lipinski, Daniel M},
title = {The Co-Transduction Conundrum: Improving Dual rAAV Delivery Through Co-Administration of Capsid Serotypes With Complementary Tropism},
journal = {Translational Vision Science & Technology},
year = {2025},
doi = {10.1167/tvst.14.11.38}
}
EUVIMED